Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors

The current standard treatment of myopic choroidal neovascularisation (mCNV) is intravitreal injection of VEGF antagonists. This study was proposed to assess efficacy and safety of intravitreal bevacizumab (IVB) for the treatment of mCNV across a 10-year follow-up. Thirty eyes of thirty patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallone, Fabiana, Giustolisi, Rosalia, Franzone, Federica, Marenco, Marco, Plateroti, Rocco, Nebbioso, Marcella, Lambiase, Alessandro, Gharbiya, Magda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541117/
https://www.ncbi.nlm.nih.gov/pubmed/34681267
http://dx.doi.org/10.3390/ph14101042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541117/
https://www.ncbi.nlm.nih.gov/pubmed/34681267
http://dx.doi.org/10.3390/ph14101042

Ejemplares similares